Notice of Correction to Letter of Reference Receipt Date in RFA-DA-18-019 NIDA Avant-Garde Award Program for HIV/AIDS and Drug Use Research (DP1, Clinical Trial Optional)

Notice Number: NOT-DA-18-028

Key Dates
Release Date: July 19, 2018

Related Announcements
RFA-DA-18-019

Issued by
National Institute on Drug Abuse (NIDA)

Purpose

The purpose of this notice is to inform interested applicants of a correction to the Letters of Reference submission deadline for RFA-DA-18-019 "NIDA Avant-Garde Award Program for HIV/AIDS and Drug Use Research (DP1, Clinical Trial Optional)". Specifically, the deadline for submitting letters of reference is 5:00 p.m. (local time of applicant organization), August 14, which is the Application Due Date.

Section IV. Application Submission Information

7. Other Submission Requirements and Information

Letters of Reference

Currently Reads:

The letter of reference submission deadline: The deadline for receipt of letters is 5:00 p.m. (local time of the referee) on the Application Due Date of the competition, July 31.

Letters must be submitted to the Commons at (https://public.era.nih.gov/commons/public/reference/submitReferenceLetter.do?mode=new) by 5:00 p.m. (local time of the referee), on the Application Due Date of the competition, Aug. dd.

Modified to Read:

The letter of reference submission deadline: The deadline for receipt of letters is 5:00 p.m. (local time of the referee) on the Application Due Date of the competition, August 14.

Letters must be submitted to the Commons at (https://public.era.nih.gov/commons/public/reference/submitReferenceLetter.do?mode=new) by 5:00 p.m. (local time of the referee), on the Application Due Date of the competition, Aug. 14.

All other aspects of this FOA remain the same.

Inquiries

Please direct all inquiries to:

Redonna Chandler, PhD
National Institute on Drug Abuse
Telephone: 301-402-1919
Email: redonna.chandler@nih.gov